The agenda includes:
1 Prepare a position paper on the evaluation of the drug Talvey (talquetamabum) under drug program B.54. "Treatment of patients with plasmocytic myeloma" (ICD-10: C90.0).
2 Prepare a position paper on the evaluation of the drug Libtayo (cemiplimabum) under the drug program B.6. "Treatment of patients with lung cancer (ICD-10: C34) and pleural mesothelioma (ICD-10: C45)".
3 Prepare a position paper on the evaluation of the drug Libtayo (cemiplimabum) under drug program B.159. "Treatment of patients with cervical cancer (ICD-10: C53)".
4 Prepare a position paper on the evaluation of the drug Tavneos (avacopanum) under drug program B.75. "Treatment o...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
